Edition:
United States

Medtronic PLC (MDT.N)

MDT.N on New York Stock Exchange

72.40USD
9:33am EST
Change (% chg)

$0.39 (+0.54%)
Prev Close
$72.01
Open
$72.59
Day's High
$72.66
Day's Low
$72.40
Volume
108,301
Avg. Vol
1,466,140
52-wk High
$89.27
52-wk Low
$71.03

Latest Key Developments (Source: Significant Developments)

FDA says Heartware Inc recalling HVAD pumps due to design problem with driveline connector
Tuesday, 25 Oct 2016 08:59am EDT 

U.S. Food and Drug Administration: Heartware Inc recalling the HVAD pumps due to a design problem with the driveline connector .contamination of Heartware's driveline may result in fluid or other material entering pump, causing electrical issues or pump stops.  Full Article

U.S. FDA approves first automated insulin delivery device for type 1 diabetes
Wednesday, 28 Sep 2016 01:34pm EDT 

U.S. FDA: FDA approves first automated insulin delivery device for type 1 diabetes . Approved Medtronic’s MiniMed 670G hybrid closed looped system . Medtronic is currently performing clinical studies to evaluate the safety and effectiveness of device in diabetic children 7-13 years old .As part of approval, FDA is requiring a post-market study to better understand how device performs in "real-world settings".  Full Article

Medtronic receives FDA clearance of TrailBlazer angled peripheral support catheter
Wednesday, 28 Sep 2016 09:00am EDT 

Medtronic Plc : Medtronic receives FDA clearance of TrailBlazer angled peripheral support catheter .FDA clearance was received on September 23, 2016.  Full Article

Medtronic Q1 adj EPS of $1.03
Thursday, 25 Aug 2016 06:45am EDT 

Medtronic PLC : Q1 revenue $7.2 billion . Says company reiterates FY 2017 revenue outlook and EPS guidance . Qtrly GAAP diluted EPS of $0.66 . Qtrly non-GAAP diluted EPS of $1.03 . Q1 earnings per share view $1.01, revenue view $7.17 billion -- Thomson Reuters I/B/E/S . Qtrly Restorative Therapies Group worldwide revenue of $1.772 billion decreased 2 percent . Qtrly Spine Division revenue of $645 million decreased 6 percent, or was flat on a cccw basis . Qtrly Cardiac and Vascular group worldwide revenue of $2.518 billion decreased 2 percent . FY 2017 earnings per share view $4.66, revenue view $29.95 billion -- Thomson Reuters I/B/E/S .  Full Article

Medtronic reports a passive stake of 8.6 pct in Mazor Robotics
Monday, 22 Aug 2016 05:13pm EDT 

Mazor Robotics Ltd :Medtronic Plc reports a passive stake of 8.6 pct in Mazor Robotics Ltd as of August 11, 2016 - SEC filing.  Full Article

Medtronic Plc CEO Omar Ishrak's 2016 total compensation was $15.3 mln versus $38.5 mln in 2015
Wednesday, 10 Aug 2016 08:40am EDT 

Medtronic Plc : CFO Gary Ellis' FY 2016 total compensation $6.1 million versus $5.5 million in FY 2015 . Medtronic Plc Ceo's 2015 Total Compensation Included $24.7 Mln Of "All Other Compensation" Payments -SEC filing .Medtronic Plc CEO Omar Ishrak's 2016 total compensation was $15.3 million versus $38.5 million in 2015 -SEC filing.  Full Article

Medtronic says CoreValve Evolut R System TAVI to get CE mark
Monday, 1 Aug 2016 11:00am EDT 

Medtronic Plc :CoreValve Evolut R System TAVI to receive CE mark for intermediate risk aortic stenosis patients.  Full Article

Nuvasive agrees to settle patent litigation with Medtronic
Thursday, 30 Jun 2016 04:05pm EDT 

Nuvasive Inc : Nuvasive agrees to settle patent litigation with Medtronic . Nuvasive and Medtronic reached agreement on terms for settlement of previously disclosed patent infringement lawsuits . Company and Medtronic intend to enter into a definitive settlement agreement within 15 days . Reached agreement on terms for withdrawal from proceedings in United States patent and trademark office . After settlement agreement, company will make a one-time payment of $45 million to medtronic .Parties will release each other from any and all liabilities arising out of litigation.  Full Article

Moody's - Medtronic's Heartware deal and dividend increase are credit negative
Tuesday, 28 Jun 2016 02:40pm EDT 

Moody's :Medtronic's Heartware deal and dividend increase are credit negative.  Full Article

Heartware required to pay Medtronic $27.5 mln in case of termination of merger agreement
Monday, 27 Jun 2016 10:21am EDT 

Heartware International : In connection with termination of merger agreement, company will be required to pay Medtronic, termination fee of $27.5 million Source: (http://1.usa.gov/28YgSjw ) Further company coverage: [HTWR.O] (Bengaluru Newsroom: +1 646 223 8780).  Full Article

BRIEF-Medtronic announces U.S. launch of integrated health solutions

* Medtronic announces U.S. launch of integrated health solutions with university hospitals agreement Source text for Eikon: Further company coverage: